Law Offices of Howard G. Smith announces an investigation on behalf of Chinook Therapeutics, Inc. (“Chinook” or the “Company”) (NASDAQ: KDNY) investors concerning the Company’s possible violations of federal securities laws.
On May 16, 2023, Muddy Waters Research published a report alleging that Chinook’s lead product candidate, atrasentan, “has been shown to be harmful to patients’ cardiovascular health,” and that “AbbVie and Chinook seem to …
Gain insights, receive dynamic opportunities directly to your inbox. Sign up now…
Catalyzing Investor Engagement, InvestorHyve employs cutting-edge digital marketing solutions, advanced analytics, and an all-encompassing marketing and communications platform to revolutionize corporate interactions with stakeholders. Join us at InvestorHyve and step confidently into the future of corporate engagement
Ready to revolutionize your investor engagement strategy? Join InvestorHyve today and unlock a world of seamless connectivity, personalized interactions, and empowered investor relationships that drive success.
Copyright © 2024. All Rights Reserved.
